AJCN Cancer Health Disparities Conference
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kasarskis, E. J.
Right arrow Articles by Schuna, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kasarskis, E. J.
Right arrow Articles by Schuna, A.
Agricola
Right arrow Articles by Kasarskis, E. J.
Right arrow Articles by Schuna, A.

American Journal of Clinical Nutrition, Vol 33, 2609-2612, Copyright © 1980 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Serum alkaline phosphatase after treatment of zinc deficiency in humans

EJ Kasarskis and A Schuna

The response of serum alkaline phosphatase (AP) during the first 2 weeks of zinc (Zn) replacement therapy was studied retrospectively in three Zn-deficient adults. The ratio of the maximal posttreatment to pretreatment serum AP level (AP ratio) correlated inversely with pretreatment serum Zn level. A similar linear relationship was apparent when the AP ratio was calculated from published cases of Zn deficiency of diverse etiologies. Serial determinations of serum AP and calculation of the AP ratio during a trial of Zn therapy may provide biochemical confirmation of the adequacy of Zn replacement and could potentially be useful in detection of subclinical Zn deficiency.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by The American Society for Nutrition